Who
Stephen Feider
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Beta Bionics.
In numbers
- Trades disclosed
- 73
- Buys
- 0
- Sells
- 17
- Bought
- $0
- Sold
- $3.2M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 29 Jan 2025
- Last trade
- 2 Sep 2026
- Last filed
- 3 Sep 2026
Companies traded
Activity over time
1 Jun 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Sep 2026filed 3 Sep 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $128K6,675 at $19.11 | filing |
| 2 Sep 2026filed 3 Sep 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $128K6,675 at $19.11 | filing |
| 29 Jun 2026filed 2 Jul 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Code M | $25K4,896 at $5.10 | filing |
| 29 Jun 2026filed 2 Jul 2026 | BBNX Beta Bionicsoption or derivative · Medical Devices | SEC FORM 4 Code M | —4,896 at $0.00 | filing |
| 29 Jun 2026filed 2 Jul 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $83K4,896 at $17.03 | filing |
| 29 Jun 2026filed 2 Jul 2026 | BBNX Beta Bionicsoption or derivative · Medical Devices | SEC FORM 4 Code M | —4,896 at $0.00 | filing |
| 29 Jun 2026filed 2 Jul 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Code M | $25K4,896 at $5.10 | filing |
| 29 Jun 2026filed 2 Jul 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $83K4,896 at $17.03 | filing |
| 29 Jun 2026filed 30 Jun 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Code M | $25K4,896 at $5.10 | filing |
| 29 Jun 2026filed 30 Jun 2026 | BBNX Beta Bionicsoption or derivative · Medical Devices | SEC FORM 4 Code M | —4,896 at $0.00 | filing |
| 29 Jun 2026filed 30 Jun 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $83K4,896 at $17.03 | filing |
| 29 Jun 2026filed 30 Jun 2026 | BBNX Beta Bionicsoption or derivative · Medical Devices | SEC FORM 4 Code M | —4,896 at $0.00 | filing |
| 29 Jun 2026filed 30 Jun 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Code M | $25K4,896 at $5.10 | filing |
| 29 Jun 2026filed 30 Jun 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $83K4,896 at $17.03 | filing |
| 26 Jun 2026filed 2 Jul 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Code M | $26K5,104 at $5.10 | filing |
| 26 Jun 2026filed 2 Jul 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $87K5,104 at $17.05 | filing |
| 26 Jun 2026filed 2 Jul 2026 | BBNX Beta Bionicsoption or derivative · Medical Devices | SEC FORM 4 Code M | —5,104 at $0.00 | filing |
| 26 Jun 2026filed 2 Jul 2026 | BBNX Beta Bionicsoption or derivative · Medical Devices | SEC FORM 4 Code M | —5,104 at $0.00 | filing |
| 26 Jun 2026filed 2 Jul 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Code M | $26K5,104 at $5.10 | filing |
| 26 Jun 2026filed 2 Jul 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $87K5,104 at $17.05 | filing |
News
Investor Notification: Beta Bionics ($BBNX) Investors Are Reminded to Contact BFA Law About the Ongoing Securities Fraud Class Action to Recover LossesBBNX · thesudburystar.com · 24 Oct 2026BBNX DEADLINE ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important November 3 Deadline in Securities Class Action - BBNXBBNX · wallstreet-online.de · 22 Oct 2026BETA BIONICS, INC. (NASDAQ: BBNX) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by November 3, 2026BBNX · prnewswire.com · 20 Oct 2026
0 headlines in the last 90 days name Stephen Feider; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.